New-onset diabetes and nephropathy after renal transplantation

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 247-255

  Guitard, Joelle ^a   Rostaing, Lionel ^a,b   Kamar, Nassim ^a,b  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ANIMAL; ARTICLE; DIABETES MELLITUS; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; PREVALENCE; RISK FACTOR;

ADRENAL CORTEX HORMONES; ANIMALS; DIABETES MELLITUS; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; PREVALENCE; RISK FACTORS;

EID: 84925965041     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000325778     Document Type: Article

References (30)

1. Pascual J, Galeano C, Royuela A, Zamora J: A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation. Transplantation 2010;90:343-349.
2. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3:178-185. (Pubitemid 36323115)
3. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD: New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67:2415-2421. (Pubitemid 41623405)
4. Ducloux D, Kazory A, Chalopin JM: Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005;79: 438-443. (Pubitemid 40280176)
5. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S: Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: An analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am J Kidney Dis 2010;56:1127-1139.
6. Miles AM, Sumrani N, Horowitz R, Homel P, Maursky V, Markell MS, Distant DA, Hong JH, Sommer BG, Friedman EA: Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 1998;65:380-384. (Pubitemid 28095966)
7. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC: Incidence and cost of new onset diabetes mellitus among U.S. waitlisted and transplanted renal allograft recipients. Am J Transplant 2003;3:590-598. (Pubitemid 36612842)
8. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002;25:583-592.
9. Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrancois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY: Diabetes mellitus after kidney transplantation: A French multicentre observational study. Nephrol Dial Transplant 2007;22:1986-1993. (Pubitemid 47244771)
10. Sharif A, Moore RH, Baboolal K: The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation 2006;82:1667-1672. (Pubitemid 46035649)
11. Porrini E, Moreno JM, Osuna A, Benitez R, Lampreabe I, Diaz JM, Silva I, Dominguez R, Gonzalez-Cotorruelo J, Bayes B, Lauzurica R, Ibernon M, Moreso F, Delgado P, Torres A: Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: A prospective and multicenter study. Transplantation 2008;85:1133-1138. (Pubitemid 351590191)
12. Kuypers DR, Claes K, Bammens B, Evenepoel P, Vanrenterghem Y: Early clinical assessment of glucose metabolism in renal allograft recipients: Diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant 2008;23:2033-2042. (Pubitemid 351768147)
13. Rodrigo E, Fernandez-Fresnedo G, Valero R, Ruiz JC, Pinera C, Palomar R, Gonzalez-Cotorruelo J, Gomez-Alamillo C, Arias M: New-onset diabetes after kidney transplantation: Risk factors. J Am Soc Nephrol 2006; 17:S291-S295. (Pubitemid 44865264)
14. Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D: IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J Am Soc Nephrol 2006;17: 2333-2340. (Pubitemid 44141925)
15. Ghisdal L, Baron C, Le Meur Y, Lionet A, Halimi JM, Rerolle JP, Glowacki F, Lebranchu Y, Drouet M, Noel C, El Housni H, Cochaux P, Wissing KM, Abramowicz D, Abramowicz M: TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J Am Soc Nephrol 2009;20:2459-2467.
16. Aasebo W, Midtvedt K, Gretland Valderhaug T, Leivestad T, Hartmann A, Varberg Reisaeter A, Jenssen T, Holdaas H: Impaired glucose homeostasis in renal transplant recipients receiving basiliximab. Nephrol Dial Transplant 2010:25:1289-1293.
17. Roland M, Gatault P, Al-Najjar A, Doute C, Barbet C, Chatelet V, Laouad I, Marliere JF, Nivet H, Buchler M, Lebranchu Y, Halimi JM: Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant 2008;8:1719-1728.
18. Bayes B, Granada ML, Pastor MC, Lauzurica R, Salinas I, Sanmarti A, Espinal A, Serra A, Navarro M, Bonal J, Romero R: Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplant 2007;7: 416-422. (Pubitemid 46096335)
19. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G: Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Metaanalysis of clinical studies. Am J Transplant 2005;5:2433-2440.
20. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC: Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002;13:1374-1380. (Pubitemid 34441419)
21. Kidney Disease: Improving Global Outcomes (KDIGO): Prevention, diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008;72(suppl 109):S1-S99.
22. Heisel O, Heisel R, Balshaw R, Keown P: New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004;4:583-595. (Pubitemid 38523581)
23. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007;7:1506-1514. (Pubitemid 46776239)
24. van Hooff JP, Christiaans MH, van Duijnhoven EM: Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005;79:1465-1469. (Pubitemid 40847574)
25. Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Morkrid L, Jenssen T, Hartmann A: Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation. Clin Transplant 2009;23:511-518.
26. Ghisdal L, Bouchta NB, Broeders N, Crenier L, Hoang AD, Abramowicz D, Wissing KM: Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: A single-centre experience in renal transplanted patients and review of the literature. Transpl Int 2008;21:146-151.
27. Luan FL, Zhang H, Schaubel DE, Miles CD, Cibrik D, Norman S, Ojo AO: Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant 2008;8:1871-1877.
28. Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuno-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M: Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005;79:807-814. (Pubitemid 40546200)
29. Walczak D, Calvert D, Oberholzer J, Testa G, Sankary H, Benedetti E: Effect of race on the occurrence of posttransplant diabetes in kidney transplant recipients treated with early steroid discontinuation. Transplant Proc 2005;37:819-821. (Pubitemid 40590712)
30. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P: A prospective, randomized, double-blind, placebocontrolled multicenter trial comparing early (7 day) corticosteroid cessation versus longterm, low-dose corticosteroid therapy. Ann Surg 2008;248:564-577.